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ABSTRACT  Recent studies  have  demonstrated  that tropoelastin  and  elastin-derived  peptides 
are  chemotactic  for fibroblasts  and  monocytes.  To identify  the chemotactic  sites on elastin, 
we  examined  the  chemotactic  activity  of  VaI-Gly-VaI-Ala-Pro-Gly  (VGVAPG),  a  repeating 
peptide  in  tropoelastin.  We  observed  that  VGVAPG  was  chemotactic  for  fibroblasts  and 
monocytes,  with  optimal  activity  at  ~10  -8 M, and  that the chemotactic  activity  of VGVAPG 
was  substantial  (half  or  greater)  relative  to  the  maximum  responses  to  other  chemotactic 
factors  such  as  platelet-derived  growth  factor  for  fibroblasts  and  formyl-methionyl-leucyl- 
phenylalanine  for  monocytes.  The  possibility  that at least part of the chemotactic  activity  in 
tropoelastin  and  elastin  peptides  is contained  in VGVAPG  sequences was supported  by the 
following:  (a)  polyclonal  antibody  to  bovine  elastin  selectively  blocked  the  fibroblast  and 
monocyte chemotactic  activity  of both elastin-derived  peptides and VGVAPG; (b) monocyte 
chemotaxis to VGVAPG was selectively  blocked  by preexposing the cells to elastin  peptides; 
and (c) undifferentiated  (nonelastin  producing)  bovine  ligament fibroblasts,  capable of chem- 
otaxis  to  platelet-derived  growth  factor,  did  not show chemotactic  responsiveness  to either 
VGVAPG or elastin  peptides until after matrix-induced  differentiation  and the onset of elastin 
synthesis.  These studies suggest that small  synthetic  peptides  may be able to reproduce the 
chemotactic activity associated  with elastin-derived  peptides and tropoelastin. 
Chemotactic activity has been  associated with  several com- 
ponents  of the  extracellular matrix including collagen (18), 
fibronectin  (1,  5,  17),  laminin  (27),  peptides  of insoluble 
elastin (6, 22, 23), and tropoelastin (23). The sites of chemo- 
tactic activity on  collagen (16) and  fibronectin (1,  25)  have 
been  partially localized, however the chemotactically active 
regions of laminin and elastin have not yet been established. 
The present study was undertaken  to  identify the  site(s) of 
chemotactic activity on elastin. 
In  approaching  the  molecular  basis  of the  chemotactic 
activity of elastin peptides two points seemed important: first, 
the presence of fibroblast chemotactic activity in tropoelastin 
(23), the soluble precursor of insoluble elastin (20), suggested 
that the lysine-derived cross-links characteristic of insoluble 
elastin are not essential for the chemotactic activity of elastin 
peptides; and  second, the  presence of repeating peptide se- 
quences  in  tropoelastin (4,  19)  directed us to  look at these 
peptide  repeats  as  the  possible  source  of the  chemotactic 
activity. In this report, we present evidence that some of the 
chemotactic activity of elastin is associated with Val-Gly-Val- 
Ala-Pro-Gly  (VGVAPG),~ a hexamer that repeats six times in 
one tryptic fragment of porcine tropoelastin (20). 
MATERIALS  AND  METHODS 
Preparation of Elastin-derived Peptides:  Bovine  ligament  elas- 
tin, obtained from Elastin Products (St. Louis, MO), was solubilized  with 
porcine  pancreatic  elastase  (Sigma  Chemical  Co., St. Louis,  MO) by incubation 
at a substrate  to enzyme ratio of I:I00 (wt/wt) for 24 h at 37"C. The elastase 
was removed from the elastin  digest  by affinity  chromatography  as previously 
described  (23) and the resultant  elastin  peptides  were lyophilized.  The concen- 
tration of elastin  peptides  in solution  was based  upon the dry weight. 
Abbreviations  used in this paper.  Boc, tert-butyloxycarbonyl;  Bzl, 
benzyl ester; C5fr, the chemotactic fragments of human C5; EtOAc, 
ethyl acetate;  FMLP, formyl-methionyl-leucyl-phenylalanine;  m.p., 
melting point; PDGF, platelet-derived  growth factor; Pet, petroleum; 
VGVAPG, valyl-glycyl-valyl-alanyl-prolyl-glycine. 
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Bachem Inc. (Torrance, CA) and were of  the L-configuration, except for glycine. 
Isobutyl chloroformate,  l-(3-dimethylaminopropyl)-3-ethyl  carbodiimide  hy- 
drochloride, and l-hydroxybenzotriazole  were purchased from Aldrich Chem- 
ical Co.  (Milwaukee,  WI).  Melting points were determined  with a  Thomas 
Hoover apparatus and are uncorrected. Thin layer chromatography (TLC) was 
performed on Whatman silica gel plates (Whatman, Inc., Clifton, N  J) with the 
following solvent  systems:  chloroform  (C), methanol  (M), acetic  acid  (A); 
relative flow rate  (R  r), CM  (5:1); R,~  CMA (95:5:3); R~ CMA (85:15:3); R~ 
CMA (75:25:3); R~ butanol:acetic acid:water:ethyl acetate ( 1: l :  1:1). The purity 
of the peptides was also confirmed  by carbon-13  nuclear magnetic resonance 
spectra obtained  on a JEOL PFI"  100 pulse spectrometer  operating at 25.15 
MHz  with  proton  noise  spin  decoupling  and  an  internal  deuterium  lock. 
Elemental analyses were performed by MicAnal (Tucson, AZ). 
(a)  Boc-Val-Gly-OBzl: To tert-hutyloxycarhonyl-valine  (Boc-Val) (8.69 g, 
0.04 tool) in acetonitrile (100 ml) cooled to 0*C was added N-methyl morpho- 
line (4.4 ml, 0.04 tool). The solution was cooled to -15"C and isobutylchloro- 
formate (5.24 ml, 0.04 mol) was added slowly under stirring while maintaining 
the temperature  at -15 -+ l*C. After stirring the reaction  mixture for 15 min. 
at this temperature,  a pre-cooled (-10*C)  solution  of giycine-benzyl-ester p- 
tosylate (13.5 g, 0.04  tool) and N-methyl  morpholine  (4.4 ml, 0.04  mol)  in 
dimethyl formamide,  35 ml, was added and stirred overnight at room temper- 
ature.  Acetonitrile  was  removed  under  reduced  pressure  and  the  residual 
dimethyl  formamide  solution  was poured into a cold 4%  NaHCO3 solution 
and stirred for 30 rain. The precipitate  obtained  was filtered, washed sequen- 
tially with water, 20% citric acid solution, and water and dried to obtain  13.5 g 
of the product  (yield: 92.6%). A sample  was crystallized from ethyl acetate 
(EtOAc)/petroleum  (Pet) ether to give a product with a melting point (m.p.) 
80-82"C;  TLC: R~  0.86; R~  0.53; R~  0.93. The  analysis  calculated  for 
ClgH28N20:I 1/2H20  was C,  62.44%;  H,  7.80%; N,  7.65%. The  observed 
composition was C, 62.62%; H, 7.74%; N, 7.69%. 
(b) Boc-Val-Gly-OH: Boc-Val-Gly-OBzl (5 g,  13.72 mmol) in glacial acetic 
acid (50 ml) was hydrogenated  at 40 psi in the presence of 10%  palladium- 
carbon catalyst (0.5 g for 6 h. The catalyst was filtered and the filtrate concen- 
trated under reduced pressure. The residue was taken in 4% NaHCO3 solution 
and extracted  with  EtOAc (three  times).  The aqueous solution  was cooled, 
acidified to pH 2 and the  peptide extracted into CHCl3 after saturating with 
NaCl. The combined  CHCI3 extracts were washed once with saturated  NaCl 
solution, dried over anhydrous MgSO4 and the solvent removed under reduced 
pressure. The peptide was precipitated  from  EtOAc/Pet  ether,  3.83 g (Yield: 
100%); m.p. 109- l 13"C; TLC: R~ 0.25; R~ 0.5 l, R~ 0.7. The analysis calculated 
for CI2H22N20~ was C, 52.54%; H, 8.08%; N,  10.21%. The observed compo- 
sition was C, 52.34%; H, 8.22%; N, 10.28%. 
(c) BOC-VaI-GIy-VaI-AIa-Pro-GIy-OCH3:  Boc VAPG-OCHa (14) (6 g, 12.89 
mmol) was treated with trifluoroacetic acid, 60 ml, for 1 h and the trifluoroa- 
cetic acid removed  under reduced pressure.  The  residue was triturated  with 
ether:Pet ether (1:1), decanted,  and the oily residue was dried over P205 and 
NaOH in a vacuum desiccator. To II (2.92 g, 10.65 mmol) and 1-hydroxyben- 
zotriazole  (1.79g,  11.715 mmol) in dimethyl  formamide  (25  ml) cooled to 
- 15"C was added  l-(3-dimcthylaminopropyl)-3-ethyl  carbodiimide hydrochlo- 
ride (2.25 g,  11.715 mmol) and stirred for  15  min. To this was added a pre- 
cooled (-10*C)  solution  of the above trifluoroacetic  acid salt of the  peptide 
(5 g, 10.65 mmol) in dimethyl formamide  (25 ml). The reaction  mixture was 
allowed to come to room temperature  and  stirred  over  night.  Solvent  was 
removed under reduced pressure and the residue taken in CHCI3 and extracted 
with  water,  4%  NaHCO~, water,  10%  citric  acid, water,  dried  over  anhyd. 
MgSO4 and the solvent removed. The peptide was crystallized from EtOAc/ 
Pet ether, 3.08 g (yield: 47.2%), m.p. shrinks at 97"C and completely melts at 
118"C; TLC: R~ 0.61; Rj; 0.3; Rj; 0.8. Analysis calculated for C28H48NrO9 H20 
was C, 53.31%; H, 7.99%; N,  13.32%. The observed analysis was C, 53.40%; 
H, 7.81%; N, 13.27%. 
(d) Boc-Val-Gly-Val-Ala-Pro-Gly-OH: Boc-Val-Gly-Val-Ala-Pro-Gly-OCH3 
(1 g,  1.62 mmol) in methanol  (10 ml) was stirred with  1 N NaOH (2.02 ml, 
2.023  mmol) for  1 h  and  methanol  removed  under reduced  pressure.  The 
residue was diluted with water and extracted with EtOAc. The aqueous solution 
was cooled, acidified to pH 2, saturated  with NaCI and extracted with CHC13 
(three times). The combined CHCI3 extracts were washed with saturated NaC1, 
dried over anhydrous MgSO4, and the solvent removed under reduced pressure. 
The peptide was crystallized from EtOAc/Pet  ether, 0.95 g (yield: 98%), m.p. 
125-130"C  (decomp);  TLC: R~  0.36; R~  0.56. Analysis  calculated  for 
C27H46NrO9 was C, 54.16; H, 7.74%; N, 14.03%. The observed analysis was C, 
54.2%; H, 8.25%; N, 14.17%. 
(e)  HCO2H.H-VaI-Gly-Val-AIa-Pro-Gly-OH:  A  solution  of Boc-Val-Gly- 
Val-Ala-Pro-Gly-OH (0.6 g,  1 mmol) in 95-97%  formic  acid (16.5 ml) was 
stirred for 2.5 h and formic acid removed under reduced pressure. The residue 
was dissolved in water and lyophilized to obtain  the title compound in quan- 
titative yield. TLC: R~ 0.55. 
Chemotactic  Factors:  Platelet-derived growth factor (PDGF),  puri- 
fied from outdated  platelet packs (3), was kindly provided by Dr. Thomas F. 
Deuel, (Jewish Hospital at Washington  University Medical Center, St. Louis, 
MO) and C5-derived chemotactic activity from human serum (C5fr) was a gift 
from  Dr.  Donald  k  Kreutzer  (University  of Connecticut  Health  Center, 
Farmington).  Formyl-methionyl-leucyl-phenylalanine  (FMLP) was purchased 
from Sigma Chemical Corp. (St. Louis, MO). 
Antielastin  IgG:  IgG was prepared  from normal rabbit  serum and 
from rabbit antiserum  to bovine ligamentum  nuchae alpha-elastin by column 
chromatography  using DEAE AffigeI-Blue  (Bio-Rad Laboratories, Richmond, 
CA) as described (12). The specificity of the antiserum  for elastin  has been 
demonstrated  previously (9, 10). 
Cells:  Fetal bovine ligament nuchae  fibroblasts were obtained and cul- 
tured as previously described (l l). Human mononuclear peripheral blood cells 
were separated  from blood,  donated  by healthy volunteers,  using Ficoll-Hy- 
paque  gradients  (2). Undifferentiated  ligament  fibroblasts  were induced  to 
synthesize elastin by contact with extracellular matrix  material from the liga- 
ment of a late gestation calf using procedures recently presented (13). 
Assays of Chemotaxis:  Chemotaxis was assayed by a double micro- 
pore membrane system in modified Boyden chambers, by previously described 
procedures (21, 22), Briefly,  the lower compartment of  the chamber, containing 
240  #1  of test  material  or  basal  medium,  was  separated  from the  upper 
compartment containing  360 ul of cell suspension (1.2 x  105 fibroblast/ml  or 
2.5  x  106  mononuclear cells/ml),  by either  a  8 #m (fibroblast) or a  5 #m 
(monocyte)  polycarbonate  membrane (Nucleopore  Corp.,  Pleasanton,  CA) 
which was overlying a 0.45-t~m cellulose nitrate  membrane (Millipore Corp., 
Bedford,  MA). After  the  upper and  lower  compartments were  filled, the 
chambers were incubated for either 2 h (monocytes) or 6 h (fibroblasts) at 37°C 
in 5% CO=-balance air. The chambers were then disassembled and the mem- 
brane  pairs removed and stained  with hematoxylin.  In each experiment,  the 
data points represent the mean of cell counts of five high power (x 400) fields 
on each of three membrane pairs. The results are reported as the mean number 
of cells that migrated through the  upper membrane,  corrected for blanks  as 
determined  by chambers containing  only medium in the lower compartment. 
All experiments  included  positive controls:  for fibroblast studies,  PDGF,  30 
ng/ml (l nM), was put in the lower compartment; for monocyte studies, FMLP, 
l0  -s M and/or C5fr was put in the lower compartment. 
To  assess the  capacity  of elastin  peptides  and  VGVAPG  to desensitize 
monocytes to the chemotactic  activity of elastin peptides and VGVAPG, we 
incubated  mononuclear cells for 30 min at 25"C with either elastin peptides, 
100 #g/ml or VGVAPG,  l0  -s M, respectively, and then washed the cells three 
times with basal medium. Chemotaxis was then assayed as described above. 
The  effects of antielastin  IgG  on  chemotaxis  to  VGVAPG  and  elastin 
peptides  were  determined  by  preincubating  antielastin  IgG  with  either 
VGVAPG or elastin peptides for 60 rain at 37°C and then assaying the mixture 
for chemotactic activity. In these experiments, controls included (a) VGVAPG 
or elastin  peptides  preincubated  with  preimmune IgG and  (b) mixtures  of 
antielastin IgG preincubated with PDGF. 
RESULTS 
Chemotactic Activity of VGVAPG 
VOVAPG caused fibroblast and monocyte migration, with 
a  maximal  activity  in  the  range  of  10-9-10 -s  M  (Fig.  1).  At 
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FIGURE  1  Fibroblast  and  monocyte  migration  in  response  to 
VGVAPG. Mean and standard error are shown, n =  15. Background 
cell  migration was  16 for the fibroblast (13) studies and  36 for the 
monocyte (11) experiments. 
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Fibroblast Chemotaxis to VGVAPG 
VGVAPG 
(M), lower 
compart- 
ment 
VGVAPG (M), upper compartment 
0  10-10  10  -9  10  -8 
0  (7)  1±0.6  0±0.7  -2±0.5 
10  -1°  4±1.0"  2±0.7  -3±0.4  1±1.0 
10  -9  15±1.7  7±1.3  0±0.4  0±0.6 
10  -8  27±1.7  13±1.8  3±0.6  1±0.7 
*  Net  cells  per  high  power  field  +  SEM,  n  =  15.  Positive  control  PDGF, 
10  -9 M  =  31  cells  per high  power  field. 
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FIGURE  2  The effect of antielastin IgG on the fibroblast chemotac- 
tic activity of VGVAPG.  In these studies background cell migration 
was 11.  (t)  No IgG. (O)  Pre-immune IgG. (&) Antielastin  IgG. The 
error bars are as in Fig. 1. 
the peak of activity, the  number of cells  that  migrated was 
nearly  as  great  as  that  observed  with  the  optimal  PDGF 
concentration for fibroblast chemotaxis, 10  -9 M (21), and the 
optimal concentration  of FMLP for monocyte chemotaxis, 
10  -s M. By "checker board analysis" the fibroblast migration 
to VAVAPG was chemotactic, not chemokinetic (Table I). 
Effect of Antielastin  IgG upon  the Chemotactic 
Activity of VGVAPG 
Polyclonal antielastin IgG, previously shown to inhibit the 
chemotactic activity of elastin peptides for monocytes (22), 
abolished  the  chemotactic  activity  of VGVAPG  (Fig.  2). 
Specificity of the inhibition was shown by demonstrating that 
antielastin IgG had no inhibitory effect against the chemotac- 
tic activity of PDGF and that pre-immune rabbit IgG exerted 
no  inhibition  upon  the  chemotactic activity of VGVAPG. 
Moreover, immune complexes consisting of VGVAPG plus 
antielastin  IgG  did  not  block  the  chemotactic  activity  of 
FMLP, indicating that these immune complexes do not have 
a generalized inhibitory effect upon chemotaxis. 
Desensitization to VGVAPG 
Preexposure of monocytes to elastin peptides before testing 
them for chemotaxis completely abolished their chemotactic 
responses to both elastin peptides and VGVAPG (Fig.  3A). 
The loss of chemotactic responsiveness was specific since the 
cells still migrated normally to two other unrelated chemotac- 
tic factors, C5fr and  FMLP.  Preincubation  with VGVAPG 
completely blocked chemotaxis to VGVAPG but only par- 
tially reduced chemotactic responses to elastin peptides (Fig. 
3 B), suggesting that elastin peptides contain chemotactically 
active sequences other than VGVAPG. 
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Chemotactic Responses of Undifferentiated 
Ligament Fibroblasts to VGVAPG 
Undifferentiated ligament fibroblasts showed no migration 
in response either to VGVAPG or elastin peptides, but were 
fully responsive to PDGF (Fig.  4, top). After these cells were 
exposed to extracellular matrix from 270-d gestation bovine 
ligamentum  nuchae,  however,  they  responded  to  both 
VGVAPG and elastin peptides (Fig. 4, bottom). 
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FIGURE  3  Monocyte  chemotaxis to C5fr,  FMLP,  elastin peptides, 
and VGVAPG  after  preincubating the  cells with  either (A)  elastin 
peptides or  (B) VGVAPG.  The  background  numbers  of migrating 
cells for these experiments were 49 and 51, respectively. The error 
bars are as in Fig.  1. 
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FIGURE  4  Chemotaxis of  undifferentiated  ligament fibroblasts to 
VGVAPG  and  elastin  peptides  before  and  after  the  cells  were 
induced  to  synthesize  elastin  by  exposing them  to  matrix  from 
differentiated ligament fibroblasts. (Top)  Before induction. (Bottom) 
After induction. Background cell migration for these studies was 19 
and 25,  respectively. (0) Elastin  peptides. ((3) VGVAPG.  The error 
bars are as in Fig. 1. The PDGF standards were 30 ng/ml, 10  -9 M. DISCUSSION 
Working with tryptic fragments of tropoelastin extracted from 
the aortas of copper-deficient pigs, Sandberg et al. (20)  have 
succeeded in sequencing nearly all of  this molecule of approx- 
imately 800  amino acid residues.  The tryptic fragments of 
tropoelastin appear to be divisible into two groups: (a) small 
peptides  of two  to  four amino  acids,  consisting  mainly of 
alanine and lysine, and thus parts of the molecule destined to 
be involved in cross-links; and (b) more hydrophobic peptides 
of  17-81  amino  acids,  some  of which  contain  repeating 
sequences (19). The principal repeating sequences are a tetra- 
peptide, GGVP, occurring several times in a peptide near the 
N-terminus,  a  pentapeptide,  PGVGV,  which  repeats  l l.4 
times  in  one  peptide  of  81  residues,  and  a  hexamer, 
VGVAPG, used in the present study, which repeats six times 
within a stretch of 57 amino acids. The functions served by 
these repeats are not yet clear, but it has been postulated that 
they have a specific role in the physical properties of elastin 
(28, 29). In addition to having chemotactic activity it is clear 
that the hexameric repeat is a  strong antigenic epitope (10), 
suggesting that this region of the molecule may be an impor- 
tant biologically active domain of elastin. 
It should be emphasized that the present work was limited 
to the repeating hexamer. The results therefore do not exclude 
the  presence  of chemotactic  activity associated  with  other 
parts of tropoelastin or elastin peptides, especially other re- 
peats. Indeed, the observations that the chemotactic activity 
to elastin peptides is only partially blocked by preexposure of 
the  target cells to  VGVAPG,  strongly suggests  that  elastin 
peptides have chemotactically active sites besides VGVAPG 
sequences. Moreover, we have not yet determined whether all 
six residues are necessary for the activity of the hexamer nor 
whether the order of the residues is critical. It should also be 
noted that while there are no sequence data on bovine elastin, 
the source of the elastin peptides used in the present work, 
studies of the amino acid composition and of the immuno- 
reactivity  of elastin  suggest  conservation  of the  sequence 
between species (9,  10, 26). 
The finding that a small hydrophobic repeating peptide in 
elastin is chemotactic for fibroblasts and monocytes is analo- 
gous to observations of chemotaxis to collagens, reported by 
Gauss-Muller et al. (5) and by Postlethwaite (16).  Interstitial 
collagens, types I, II, and IlI, and basement membrane colla- 
gens  types  IV  and  V  are  chemotactic  for  fibroblasts  and 
monocytes and the activity is retained even if the collagens 
are subjected to  proteolytic cleavage with  mammalian and 
bacterial collagenases or with cyanogen bromide. The chem- 
otactic activity of isolated collagen chains matches their ca- 
pacity to  bind  to  fibroblasts and  the  capacity  of collagen 
fragments to inhibit the binding of collagen chains to fibro- 
blasts correlates with their chemotactic activity. Of particular 
relevance to the present report, synthetic di- and tri-peptides 
from collagen containing hydroxyproline also have fibroblast 
chemotactic activity, suggesting that  cellular recognition  of 
collagens may involve very short amino acid sequences. The 
cell attachment activity of fibronectin has been localized to 
within a  30-amino acid peptide (15).  Since the chemotactic 
activity of fibronectin appears to be located near or coincident 
with the  cell attachment region of the  molecule (1,  7,  25), 
fibronectin may be another example of  an extracellular matrix 
macromolecule with chemotactic activity that will ultimately 
be localized to a small peptide segment. 
Hunninghake et al. (6) first demonstrated that monocytes 
remained chemotactically responsive to elastin peptides after 
exposure to activated serum,  suggesting that recognition of 
elastin  peptides  by  monocytes  does  not  involve  the  C5a 
receptor. The present study confirms and extends this obser- 
vation: (a) elastin peptides are shown not to utilize the FMLP 
receptors on monocytes (30); and (b) a peptide not previously 
studied for monocyte chemotaxis (VGVAPG) has been iden- 
tified as a  monocyte chemoattractant and to use neither the 
CSa or the FMLP receptors. It is also worthy of emphasis that 
being able to demonstrate that a synthetic analog of a repeat- 
ing peptide in elastin is chemotactic for fibroblasts and mon- 
ocytes strengthens the earlier reports that elastin-derived pep- 
tides  are  chemotactic  (6,  22,  23)  because  it  excludes  the 
possibility that the previously reported activity was due to a 
contaminating  substance(s)  in  proteolysed  elastin  prepara- 
tions. 
The physiological roles that chemotaxis to tropoelastin and 
elastin peptides might serve in vivo can only be speculated on 
at this time.  Recognition by monocytes might facilitate re- 
moval of proteolysed elastin.  For fibroblasts, chemotaxis to 
elastin peptides might serve to promote wound healing and 
matrix remodeling generally, however, there may be purposes 
for fibroblast recognition of elastin peptides and tropoelastin 
besides cell movement. Recognition, which we have measured 
in vitro as chemotaxis, might have a role in cell activities such 
as regulation of elastin synthesis or orientation of tropoelastin 
molecules on the cell surface to facilitate cross-linking. 
Apart  from  helping  to  identify  the  sites  of chemotactic 
activity on elastin, the results of the present study represent 
another illustration of changes in chemotactic responsiveness 
with development. We have shown elsewhere that undiffer- 
entiated ligament fibroblasts do not show chemotactic respon- 
siveness to elastin peptides until after induction of differentia- 
tion as reflected by the onset of elastin synthesis (8). Here, we 
have presented a  similar picture with respect to a  repeating 
hexamer of elastin. 
These  results  indicating  that  VGVAPG  is  an  important 
component  of the  chemotactic activity of elastin  peptides 
suggest that the  hexamer will  be a  useful probe to explore 
interactions between cells  and tropoelastin and elastin pep- 
tides  such  as  binding  reactions  and  metabolic effects.  The 
results also indicate that the  preparation of artificial elasto- 
mers using peptide repeats of tropoelastin (28,  29) may lead 
to  materials that  have biologically interesting  properties as 
well as the physical characteristics of native elastin. 
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Note Added  in Proof  Recent studies indicate that tropoelastin 
does not completely desensitize monocytes to the chemotactic activity 
of  elastin-derived peptides. Thus, domains unique to insoluble elastin 
contribute to the overall chemotactic activity of peptides generated 
from the insoluble molecule. 
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